Advertisement Arterial Remodeling Technologies names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Arterial Remodeling Technologies names new CEO

Arterial Remodeling Technologies, a developer of bioresorbable peripheral and coronary polymer stents, has appointed Machiel Leest as its new CEO.

Most recently, Mr Leest was Arterial Remodeling Technologies’s (ART’s) COO since March 2008. Prior to joining ART, he was director of R&D and regulatory affairs since May 2003 at Minvasys. Prior to joining ART, he was director of R&D and regulatory affairs since May 2003 at Minvasys.

Thierry Chignon, director of ART, said: “Because of ART’s approach of achieving temporary stenting of a traumatized angioplasty site, the company expects to benefit greatly from Machiel’s proven understanding of the development, regulatory, clinical, manufacturing and market dynamics of the bioresorbable stent sector.”